Sarepta and GenEdit partner to develop neuromuscular disease therapies

Sarepta entered a research partnership and option agreement with GenEdit to develop gene-editing therapies for neuromuscular diseases.

Related Keywords

Genedit Nanogalaxy ,Doug Ingram ,Contract Development ,Sarepta Therapeutics Inc ,Software Solutions For ,Sarepta Therapeutics ,Pharmaceutical Technology ,Non Sterile Liquid ,Monitoring Pharma ,Packaging Products ,